Therapeutic equivalence [Design Issues]

posted by raghu – India, 2011-02-09 11:07 (5261 d 07:00 ago) – Posting: # 6600
Views: 6,980

Dear Mr Kishore,

You can conduct BE study in healthy volunteers if the anticancer drug not shows any cytotoxic or any major health risk for participating healthy subjects.

Therapeutic equivalence study should be conducted in patients.

Regards
Raghu.

Complete thread:

UA Flag
Activity
 Admin contact
23,427 posts in 4,929 threads, 1,676 registered users;
28 visitors (0 registered, 28 guests [including 9 identified bots]).
Forum time: 19:07 CEST (Europe/Vienna)

Many people tend to look at programming styles and languages like religions:
if you belong to one, you cannot belong to others.
But this analogy is another fallacy.    Niklaus Wirth

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5